Pigmented lesions of the oral cavity: review, differential diagnosis, and case presentations.Journal (Canadian Dental Association)
Tracking your first week on semaglutide can reveal early glucose changes
The right choice can change based on history, medication interactions, side effects, budget, and availability
Semaglutide (GLP-1 mono-agonist) typically delivers around 14.9% loss at 68 weeks in STEP 1, against roughly 22.5% for tirzepatide 15 mg in SURMOUNT-1 [4]
Patients should never reuse used needles and should stay informed about when to take their next scheduled dose or what to do if they miss a scheduled dose
PLoS One, 18 (8), e0289616